Ambrx Investors

24 investors on Angel Roster list Ambrx in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and the Netherlands.

Investors are matched on the company name in their portfolio, so companies that share the name Ambrx can appear together.

Investors listed
24
With verified email
42%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 Ambrx investors

The most complete profiles first. Showing 24 of 24.

  • Noga YerushalmiVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Owen LozmanVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Brian BulgerVerified

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Claudia ZimmermannVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • David PorterVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Verified email available

  • Jason MehringVerified

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Javier RodriguezVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • Michael LeitnerVerified

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Sam GrayVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Verified email available

  • Cheryl Zimberlin

    Venture Capital, Corporate Venture Capital, Investor · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Christian Patze

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    SeedHealth CareDeepTechConsumer GoodsInfrastructure

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Alexander Cunynghame

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Anne

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Charlie Guyton

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Daniel Nellis

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Julian Schubert

    Venture Capital, Corporate Venture Capital · Germany

    Health CareConsumer GoodsInfrastructureChemical

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Kush Kothary

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Laurence Paredes

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Mark Kronfeld

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Nik Singhal

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Rory Pope

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Steve Adkin

    Venture Capital · United Kingdom

    Health CareHospitalsLife ScienceSoftware

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Wallace Wallace

    Venture Capital, Corporate Venture Capital · Netherlands

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Ambrx investors are on Angel Roster?

Angel Roster lists 24 Ambrx investors. 10 of them (42%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (15), Private Equity Firms (11) and Investment Banks (9). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Ambrx investors invest in?

Among those that list a stage, the most common are Seed (4).

Where are Ambrx investors based?

Most are based in the United States (9), the United Kingdom (6) and the Netherlands (3).

Which companies have Ambrx investors backed?

The most-backed portfolio companies among them are Bird Rock Bio (15), Anaphore (13), Wise (9), iCapital Network (9) and Immunocore (9).

How do I contact Ambrx investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.